Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

By afschroeder • August 5, 2025

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle EP, Freedberg KA. Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US. Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093/cid/ciaf428. Epub ahead of print. PMID: 40757869.

Tags: clinical trials, HIV, Implementation, Infectious Diseases, long-acting antiretrovirals, Publications, resistance

In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic Approach

Youssef EG, Elnesr K, Hanora A. In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic Escherichia coli Based on the 2011 German O104:H4 Outbreak Strain Using[...]

Cabotegravir pharmacokinetics in Asians with and without HIV

Han K, Abulfathi AA, Mehta RS, Nand RA, Marzinke MA, Landovitz RJ, D'Amico RD, Rinehart AR, Spreen WR, Ford SL. Cabotegravir pharmacokinetics in Asians with[...]

Depression improves the predictive accuracy of the VACS Index 2.0 for all-cause mortality among sexual minority men living with HIV in the Multicenter AIDS Cohort Study

Qian Y, Comulada WS, Hidalgo MA, Lee SJ, Friedman MR, Palella FJ, Plankey MW, D'Souza G, Detels R, Mimiaga MJ. Depression improves the predictive accuracy[...]